In the US, Vigabatrin (vigabatrin systemic) is a member of the drug class gamma-aminobutyric acid analogs and is used to treat Epilepsy, Seizure Prevention and Seizures.
US matches:
- Vigabatrin
- Vigabatrin Oral Solution
- Vigabatrin Solution
- Vigabatrin Tablets
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N03AG04
CAS registry number (Chemical Abstracts Service)
0060643-86-9
Chemical Formula
C6-H11-N-O2
Molecular Weight
129
Therapeutic Category
Antiepileptic agent
Chemical Name
5-Hexenoic acid, 4-amino-
Foreign Names
- Vigabatrinum (Latin)
- Vigabatrin (German)
- Vigabatrine (French)
- Vigabatrina (Spanish)
Generic Names
- Vigabatrin (OS: BAN, USAN)
- Vigabatrine (OS: DCF)
- MDL 71754 (IS: MerrellDow)
- RMI 71754 (IS: Merrell)
- þ-Vinyl-GABA (IS)
- Vigabatrin (PH: BP 2010)
Brand Names
- Sabril
Aventis, Brazil; Aventis, Czech Republic; Aventis, Ireland; Aventis, Luxembourg; Aventis, New Zealand; Aventis, Peru; Aventis, South Africa; Euro, Netherlands; Lundbeck, United States; Marion Merrell, Slovakia; Marion Merrell, Tunisia; Sandoz, Mexico; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Germany; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Hungary; Sanofi-Aventis, Italy; Sanofi-Aventis, Malta; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Oman; Sanofi-Aventis, Poland; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal - Sabrilan
Agis, Israel - Sabrilex
Aventis, Iceland; Euro, Netherlands; Sanofi-Aventis, Denmark; Sanofi-Aventis, Finland; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden; Sanofi-Aventis S.A., Spain
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment